What this means
This is a trial sign-up, and it has not reported any results yet. It aims to find metabolic patterns linked to losses in movement, thinking, and well-being as people age.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50 and over
- Where
- 1 site, including Texas
The science
- Registered title
- Metabolic and Functional Consequences of Aging in Health and Disease
- Trial ID
- NCT05240885 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Aging
- What is tested
- Stable tracer infusion in a postabsorptive state
- Sponsor
- Texas A&M University
- Ages
- 50 Years to no maximum
- Dates
- First posted Feb 15, 2022 · updated Oct 5, 2026
Registry summary
Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Current knowledge of the aging experience and the trajectories of physical and cognitive decline across various age groups are not well-understood, yet crucial to prevent spending added years in disease. Hence, the study objective is to develop the metabolic profile associated with aging-related disorders measured as the incidence of impaired functional capacity, cognitive function, and/or well-being.
Sites (1)
- Human Clinical Research Building, College Station, Texas, United States